MDLinx Infectious Disease – your first and best resource for the top literature, summarized and sorted to keep you current in just five minutes or less a day! Here, find exclusive content like highlighted articles you can’t miss from our physician editor D. Scott Cunningham, MD, PhD, and clinical pearls you can apply to your day to day, taken from recent Smartest Doc daily quiz competitions and Physician Reviews.
Your Unread Messages in Infectious Disease
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
No association between Lyme disease and autism
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Infectious Disease specialists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
161 A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection Journal of Hepatology, April 24, 2013 Clinical Article
162 Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients Clinical and Experimental Nephrology, April 24, 2013 Clinical Article
163 Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis Antiviral Research , April 23, 2013 Evidence Based Medicine Review Article Clinical Article
164 Molecular virology of chronic hepatitis B and C: Parallels, contrasts and impact on drug development and treatment outcome Antiviral Research , April 23, 2013 Clinical Article
165 Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation Journal of Hepatology, April 23, 2013 Review Article
166 Monoclonal Gammopathy Among Patients With Chronic Hepatitis C Virus Infection The American Journal of the Medical Sciences, April 23, 2013 Clinical Article
167 Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B European Journal of Gastroenterology & Hepatology, April 23, 2013 Clinical Article
168 Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C American Journal of Transplantation, April 23, 2013
169 Hepatitis B virus reactivation in a Juvenile Rheumatoid arthritis patient under treatment and its successful management: a complicated case Rheumatology International, April 23, 2013
170 Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study Journal of Viral Hepatitis, April 22, 2013 Review Article
171 Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine Journal of Viral Hepatitis, April 22, 2013 Clinical Article
172 Hepatitis E virus in the Western world--a pork-related zoonosis Clinical Microbiology and Infection, April 22, 2013 Review Article
173 Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells Carcinogenesis, April 22, 2013 Clinical Article
174 A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms European Journal of Gastroenterology & Hepatology, April 22, 2013 Clinical Article
175 Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management European Journal of Gastroenterology & Hepatology, April 22, 2013 Clinical Article
176 Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus Alimentary Pharmacology and Therapeutics, April 22, 2013 Clinical Article
177 Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening Full Text BMC Infectious Diseases, April 19, 2013 Evidence Based Medicine Clinical Article
178 Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection Journal of Viral Hepatitis, April 19, 2013 Clinical Article
179 Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis Scandinavian Journal of Gastroenterology, April 19, 2013 Clinical Article
180 γ-H2AX+CD8+ T lymphocytes cannot respond to IFN-α, IL-2 or IL-6 in chronic hepatitis C virus infection Journal of Hepatology, April 19, 2013 Review Article
In a study involving 37 patients with chronic hepatitis B infections, a serum bilirubin level > 5 mg/dL was predictive of progression to hepatic failure and liver-related death.
Read the article summaryIn a study involving 1607 patients > 65 years of age with community- or healthcare-acquired pneumonia, pre-morbid ambulation impairment (OR=2.61), hospitalization within 30 days of acquiring pneumonia (OR=1.93), and absence of cough and purulent sputum (OR=1.47) were shown to be associated with a significant increase in 30-day mortality.
Read the article summaryIn a retrospective study involving 225 patients with esophageal squamous cell carcinoma (ESCC) and 224 matched controls, it was shown that patients who were HPV-positive and smoked cigarettes or smoked cigarettes plus consumed alcohol were at increased risk for ESCC than patients who were HPV-negative (OR = 2.22 and 10.31, respectively).
Read the article summary1 Update on the Treatment of Patients With Non-Genotype 1 Hepatitis C Virus Infection Clinical Infectious Diseases, April 5, 2013
2 Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis Clinical Rheumatology, March 13, 2013
3 Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study Clinical Infectious Diseases, March 1, 2013
4 Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers Transplant Infectious Disease, March 13, 2013
5 Cost-Effectiveness of Screening for Chronic Hepatitis C Infection in the United States Clinical Infectious Diseases, March 7, 2013
6 Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis Antiviral Research , April 23, 2013 Evidence Based Medicine Review Article
7 Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening BMC Infectious Diseases, April 19, 2013 Free full text Evidence Based Medicine
8 Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies Annals of Internal Medicine, March 7, 2013 Free full text Review Article
9 The significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of HBV re-infection after liver transplantation Journal of Gastroenterology and Hepatology, March 1, 2013
10 Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy AIDS, April 12, 2013
11 Incident Hepatitis C Virus Infection in Men Who Have Sex With Men: A Prospective Cohort Analysis, 1984-2011 Clinical Infectious Diseases, April 24, 2013
12 Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection New England Journal of Medicine, April 25, 2013 Free full text
13 Role of hepatitis C virus substitutions and interleukin-28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response-guided therapy Journal of Viral Hepatitis, April 9, 2013
14 Are Liver Transplant Recipients Protected Against Hepatitis A and B Transplantation Proceedings, April 29, 2013 Review Article
15 IL-25 prevents and cures fulminant hepatitis through a myeloid-derived suppressor cell- dependent mechanism Hepatology, April 11, 2013 Review Article
16 Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis b with high baseline viral load (≥ 9 log10 copies/mL) Hepatology, February 4, 2013
17 Chronic HBV infection outside treatment guidelines: is treatment needed Antiviral Therapy , April 8, 2013
18 Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice European Journal of Gastroenterology & Hepatology, March 1, 2013
19 Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus Clinical Infectious Diseases, April 5, 2013
20 Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study Journal of Viral Hepatitis, April 22, 2013 Review Article
Indexed Journals in Infectious Disease: Journal of Infection, AIDS, American Journal of Infection Control more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close